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Abstract Redox behavior of midazolam was studied at a glassy carbon electrode in various buffer
systems, supporting electrolytes and pH using differential pulse, square-wave and cyclic voltam-
metry. Based on its reduction behavior, a direct differential pulse voltammetric method has been
developed and validated for the determination of midazolam in parenteral dosage. Three well-
deﬁned peaks were observed in 0.1% SLS, Britton–Robinson (BR) buffer of pH 2.5. The effect of
surfactants like sodium lauryl sulfate (SLS), cetyl trimethyl ammonium bromide (CTAB) and
Tween 20 was studied. Among these surfactants SLS showed signiﬁcant enhancement in reduction
peak. The cathodic peak currents were directly proportional to the concentration of midazolam
with correlation coefﬁcient of 0.99.
& 2012 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.
1. Introduction
Midazolam is used as short-acting sleep inducing agent for
sedation for short procedures, induction of an aesthesia, and
for prolonged sedation in intensive care units. Chemically
midazolam is represented as 8-chloro-6-(2-ﬂuorophenyl)-1-
methyl-4H-imidazo [1,5–a] benzodiazepine (Fig. 1). Midazo-
lam has strong hypnotic, anxiolytic, anticonvulsant, sedative,
amnestic and skeletal muscle relaxant properties. Benzodiaze-
pines appear to intensify the physiological inhibitory mechan-
isms mediated by gamma-aminobutyric acid (GABA), the
most common inhibitory neurotransmitter in the brain [1].
Few analytical methods have been reported for the assay of
midazolam in pharmaceutical formulations and biological
matrices. High performance liquid chromatographic (HPLC)
and liquid chromatography-mass spectrometry (LCMS) meth-
ods for measuring midazolam in human serum based on
liquid–liquid extraction by dichloromethane, isopropyl alcohol
and ethyl acetate have been reported [2–6]. Furthermore,
polarographic and voltammetric methods have also been
developed and reported for the determination of midazolam
in pharmaceutical formulation in organic solvents [7–9].
Surfactants play important roles in various ﬁelds of phar-
maceutical industries like formulation development, pharma-
ceutical analysis, etc. They have already been proven effective
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Figure 1 Structure of midazolam.
R. Jain, R.K. Yadav124in the electroanalysis of many drugs. Surface active agents are
often used as selective masking agent to improve sensitivity
and selectivity of electro-analytical methods [10,11].
Literature survey reveals that no electro-analytical method
for assay of midazolam has been reported in surfactants. In
this paper voltammetric behavior of midazolam has been
studied by employing differential pulse voltammetry (DPV),
square-wave voltammetry (SWV) and cyclic voltammetry
(CV). The effect of various surfactants (anionic, neutral and
cationic), pH and concentration of analyte on the voltam-
metric response has been evaluated. On the basis of response
in surfactants, a micelle-enhanced voltammetric method for
determination of midazolam has been developed.Figure 2 Cyclic voltammogram of midazolam (900 mg/mL)
shows peak 0, 1, 2 and 3 in presence of 0.1% SLS indicating
the irreversibility of electrode process.2. Experimental
2.1. Materials and methods
Midazolam (98% purity) was obtained from local bulk drug
supplier and was used as received. Parenteral dosage form
containing midazolam [Mezolams] labeled 1 mg mL1 was
obtained from commercial source. KCl (0.1 M) solution was
prepared in Milli-Q grade water and used as supporting electro-
lyte. Standard stock solution of midazolam (500 mg/mL) was
prepared in 0.1% SLS solution. Sample preparations of mid-
azolam (500 mg/mL) were performed in organic solvents (acet-
onitrile, dimethylformamide (DMF), 1–4 dioxane) and
surfactants (0.1% CTAB, 0.1% SLS and 0.1% Tween 20) by
mixing 1 mL of injection with 1 mL of relevant solvents or
surfactants. All solutions for recording of voltammograms were
prepared by mixing appropriate volume of stock solution, B.R.
buffer and 0.1 M KCl. All chemicals used were of analytical
reagent grade quality and were employed without further
puriﬁcation.
2.2. Instrumentation
All electrochemical measurements were performed using a
MICRO AUTOLAB TYPE III (Eco-Chemie B.V., Utrecht,
The Netherlands) potentiostat–galvanostat with 757VA com-
putrace software. The utilized electrodes were glassy carbon as
working electrode, Ag/AgCl (3 M KCl) as reference electrode
and a graphite rod as auxiliary electrode. All pH-metric
measurements were made on a Decible DB-1011 digital pH
meter ﬁtted with a glass electrode and a saturated calomel
electrode as reference.
Chromatographic experiments were performed on the HPLC
apparatus comprising a UV variable wavelength detector (SPD-
20AU, Prominence, Shimadzu Corporation, Japan), isocratic
pump (LC-20AD, Prominence) and injection valve with a 20 mLsample loop (Model 7125, Rheodyne, Cotati, CA, USA). HPLC
separations were performed as per method mentioned in British
Pharmacopoeia, using YMC ODS column (250 mm 4.6 mm,
5 mm) at a ﬂow-rate of 1.0 mL/min, detection at 220 nm at room
temperature with mobile phase (Methanol: Solution A: 72:28, v/v).
Solution A was prepared by mixing equal volume of 0.1 M ortho-
phosphoric acid and 0.03 M triethyl, adjusted pH 3.5 by 0.1M
NaOH. Sample injections were performed with a Model 701
syringe (50 mL, Hamilton, Bonaduz, Switzerland). Data acquisi-
tion and processing were performed by Spinchrom CFR software.3. Results and discussion
3.1. Electrochemical behavior of midazolam at glassy carbon
electrode
In order to understand the electrochemical process occurring
on glassy carbon electrode differential pulse voltammetry,
square-wave voltammetry and cyclic voltammetry were carried
out in organic solvents as well as surfactants.
3.1.1. Cyclic voltammetric behavior
The cyclic voltammogram of midazolam (900 mg/mL) in BR
buffer containing 0.1% SLS at glassy carbon electrode exhibits
four well deﬁned peaks (Fig. 2). No signal enhancement was
observed in peak 0 after spiking of analyte unlike other peaks
(peak 1, 2 and 3) hence this peak was labeled as peak 0. Peak
labeled as 0 may be a pre-adsorption peak not affected by the
concentration of the analyte. Peak 1 may be assigned to the
2-electron reduction of –C¼N– bond of the seven membered
ring, peak 2 to the 2-electron reduction of –C¼N– bond of the
ﬁve membered ring and peak 3 to the 2-electron reduction of
–C¼C– of the ﬁve membered ring of midazolam. No peak
could be observed in the reverse scan indicating the irrever-
sible nature of the electrode process.
3.1.2. Comparison of peak shape and response obtained by
SWV, DPV and CV
Shape and current response of voltammetric peak of midazolam
in BR and phosphate buffers at glassy carbon electrode was
investigated using SWV, DPV and CV. All the techniques gave
comparable results. SWV analysis gave two well-deﬁned peaks.
Voltammetric behavior of sedative drug 125DPV provided voltammograms with high resolution and exhib-
ited four peaks in comparison with two obtained in SWV. Better
resolution of all peaks from each other makes DPV best choice
for further analysis. The important instrumental parameters such
as pulse amplitude, pulse time, sweep rate, etc. were examined
using the selected waveform.
3.2. Optimization of operational parameters for DPV
3.2.1. Effect of pH
In all voltammograms well deﬁned peaks are obtained, which are
strongly dependent on buffers and pH of the medium. Britton–
Robinson, acetate and phosphate buffers were used in the study
and the best results in terms of peak shape were obtained in BR
buffers of pH 2.5, 3.8 and 4.5 but most intense peaks were
observed at pH 2.5. From the plot of U (V) vs. pH (Fig. 3), it is
clear that with increase in pH from 2.5 to 3.8 there is slight shift
in peak potential towards negative potential but after pH 3.8
potential shifts towards negative side are more marked indicating
participation of protons in the electrode process. Further, a plot
of I (A) vs. pH revealed that as pH was raised from 2.5 to 4.5,
the peak current decreased rapidly indicating difﬁcult reduction
with increase in pH. It may be due to the less availability of
protons at higher pH. Therefore, pH 2.5 was chosen as optimum
one for the study of midazolam reduction.
3.2.2. Effect of surfactants on voltammetric response
Voltammetric current response of midazolam (500 mg/mL) has
been studied in various organic solvents and surfactants. It is
observed that addition of cationic surfactant (SLS) into the
midazolam containing electrolyte enhanced the reduction current
signal while other surfactants like CTAB (anionic) and tween-
20(neutral) showed an opposite effect. Cationic surfactants might
combine with the substrate and strengthen their adsorption onFigure 3 Inﬂuence of pH on the cathodic peak current I (A) and
potential U (V) shift of midazolam (150 mg/mL) in 0.1% SLS, BR
buffer (pH-2.5, 3.8 and 4.5).the electrode surface, which facilitated the electron or the
substance transfer between the electrode and the solution. The
effect of SLS concentration was also examined and it was
observed that midazolam with 0.1% SLS gave well-deﬁned
reduction peaks. Limit of detection and limit of quantitation
were also found to be lower in 0.1% SLS in comparison with
organic solvent used under same experimental conditions.
Increase in the peak current in SLS may be due to
aggregation of SLS on the electrode surface in the form of
bilayers, cylinders or surface micelles. Midazolam forms self-
micelle aggregate with the SLS that affects the mass transport,
which results in changing the overpotential of the electro-
chemical process and rate of its corresponding charge transfer.
It is also observed that surfactants are highly effective in
stabilizing the voltammetric response of analyte by protecting
the electrode surface from fouling. Peak current responses of
midazolam in various media (organic solvent as well as
surfactants) are given in Fig. 4.
Various others operational parameters have also been
optimized and compiled in Table 1.
3.3. System suitability
For veriﬁcation of constant and consistent response system,
suitability tests (SST) were performed. The role of surfactant
in stabilizing the voltammetric response of analyte is already
known [12]. Stable response is key ingredient for success of
any analytical method. The signiﬁcance of SST in this study is
to ensure that the whole analytical system (including instru-
ment, reagents and electrodes) is suitable for the intended
application. Five replicate voltammetric readings of midazo-
lam standard solution (500 mg/mL) were recorded and used for
system suitability evaluation. RSD has been calculated from
ﬁve replicate voltammetric readings. Again 0.1% SLS emerged
as a suitable solvent due to lesser value of % RSD in
comparison with other surfactants and organic solvents.
3.4. Midazolam assay calculation in parenteral dosage form
Midazolam assay calculation in parenteral dosage form is
performed by employing the following expression:
Assay ðmg=mLÞ ¼ ðHT=HSÞ  ðDS=DTÞ  P=100 C
where HT is the height of midazolam peak in the test
voltammogram or chromatogram, HS is the height of mid-
azolam peak in the standard voltammogram or chromato-
gram, DS is the dilution factor for standard solution, DT is
the dilution factor for test solution, P is the potency of
midazolam standard, on as is basis and C is the label claim
of midazolam in mg per mL.
3.5. Validation of DPV method
Method validation study was conducted for assay of mid-
azolam in midazolam injection as per ICH guidelines [13].
3.5.1. Speciﬁcity
The speciﬁcity of the assay method for determination of
midazolam in midazolam injection was evaluated from benzyl
alcohol as a major compound. No interfering peaks are
found in presence of benzyl alcohol. Additionally different
Figure 4 (A) Peak current response I (A) comparison of midazolam (500 mg/mL) in different medium (Acetonitrile (ACN), 0.1% CTAB,
0.1% SLS, and 0.1% Tween 20). (B) Inset picture represents midazolam response in acetonitrile where x-axis shows potential U (V) and
y-axis represents cathodic peak current I (A). (C) Inset picture shows signiﬁcant enhancement in intensity of peak in presence of 0.1%
SLS in comparison with ACN.
Table 1 Operational parameters of proposed voltam-
metric method.
Parameter Value
Medium 0.1% SLS
Buffer BR buffer
pH 2.5
Purge time (s) 30
Stirring rate (rpm) 2000
Equilibration time (s) 10
Pulse amplitude (V) 0.050
Pulse time (s) 0.04
Voltage step (V) 0.00059
Voltage step time (s) 0.4
Sweep rate (V/s) 0.0149
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containing midazolam (500 mg/mL) and analyzed by proposed
method. The obtained percentage recoveries based on the
three replicate measurements showed no signiﬁcant interfer-
ence from benzyl alcohol. Thus the proposed procedure has
speciﬁcity to quantitate midazolam in midazolam injection.
3.5.2. Linearity
Linearity was performed by standard addition method. Lin-
earity of response for midazolam was determined in the range
of 150–900 mg/mL. Data in Fig. 5 and Table 2 indicate that the
responses are linear over the speciﬁed range of all mentioned
peaks. Various statistical parameters for linear regression
equation like slope, standard deviation, intercept, standard
deviation, correlation coefﬁcient, standard error of estimation,
sum of square of regression and sum of square of residual
have been calculated for peak 1, peak 2 and peak 3.
On the basis of maximum response, peak 1 has been
selected for analytical method validation exercise.
3.5.3. Precision
3.5.3.1. System precision. Six replicate peak current responses
of peak 1 of standard solution were recorded. Relative standard
deviation was calculated and result shown in Table 3 indicates an
acceptable level of system precision for the DPV method.3.5.3.2. Method precision. Six samples from midazolam
injection were prepared by adding equal amount of 0.1%
SLS and analyzed. Data are mentioned in Table 3. The %
RSD value has been calculated from results of six different
preparations. It indicates that this method has an acceptable
level of method precision.3.5.4. Accuracy
Benzyl alcohol was taken and spiked with known amount of
midazolam standard at three different concentration levels
each in triplicates. All samples were prepared and analyzed as
per methodology; results shown in Table 3 indicate that
accuracy of the proposed voltammetric method is acceptable.3.5.5. Stability
For stability of analytical solution standard and test solutions
were prepared and kept at 1–10 1C. Solutions were analyzed
initially and at different time intervals. Cumulative % RSD of
5 time point up to 5.5 h shows that the solutions were stable at
1–10 1C. Results are compiled in Table 3.3.5.6. Robustness
The robustness was also investigated by evaluating the inﬂuence
of slight change in some of the most important method
parameters including pH of BR buffer, concentration of KCL,
purging time, equilibration time and strength of SLS solution.
Solutions were prepared and analyzed under each modiﬁed
condition, and assay of midazolam in midazolam injection was
determined. % RSD of different determination is tabulated in
Table 3. Robustness of method is indicated by the cumulative
RSD value.3.6. Application and comparison of DPV method
with HPLC method
3.6.1. Assay of midazolam by DPV method
The developed and validated DPV method for the midazolam
determination is applied to parenteral dosage form. Results
obtained by the DPV method are shown in Table 4 and the
results show that the proposed method could be applied to
determination of midazolam.
Figure 5 (A) Differential pulse voltammograms of midazolam at various concentrations (i) 150 mg/mL, (ii) 300 mg/mL, (iii) 450 mg/mL,
(iv) 600 mg/mL, (v) 750 mg/mL and (vi) 900 mg/mL. (B) Inset picture represents linearity curve of peak 1 at different concentrations.
(C) Inset picture represents linearity curve of peak 2 at different concentrations. (D) Inset picture represents linearity curve of peak 3 at
different concentrations.
Table 2 Linearity parameters comparison of Peak 1, Peak 2 and Peak 3.
Linearity parameters Peak 1 Peak 2 Peak 3
Slope 1.27 1008 3.54E09 3.74E09
Standard deviation 6.59E10 2.19E10 1.54E10
Intercept 1.79E07 4.17E07 2.52E07
Standard deviation 3.85E07 1.28E07 9.01E08
Correlation coefﬁcient 0.989 0.985 0.993
Standard error of estimation 4.14E07 1.37E07 9.68E08
Sum of squares of regression 6.36E11 4.94E12 5.48E12
Sum of squares of residuals 6.84E13 7.54E14 3.75E14
Table 3 Analytical method validation parameters.
Parameters Results
Precision (% RSD)
System precision 2.83
Method precision 3.01
Accuracy (% Recovery)
Recovery level-1 98.1
Recovery level-2 103.4
Recovery level-3 102.9
Stability (h)
Standard solution At least 5.5
Sample solution At least 5.5
Robustness 3.97 (Overall %RSD)
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The reference reverse phase HPLC method is also used for
comparison to evaluate the validity of the developed method.
Fig. 6 shows the representative chromatogram of midazolam.
Table 4 depicts the results obtained using the proposed voltam-
metric and reference HPLC methods for three determinations.The results are compared and there are no signiﬁcant differences
between the results obtained from both the methods.
3.7. Controlled potential coulometry
Controlled potential coulometry was employed for determin-
ing number of electrons (n) transferred in electrode process.
Number of electrons n, was calculated from the charge
consumed by the desired concentration of midazolam. The
charge consumed was determined in acidic medium. For this
purpose 2 mL of 300 mg/mL midazolam in acetonitrile with
supporting electrolyte was electrolysed at 1.2 V and at 1.7 V
against reference electrode.
During the electrolysis, solutions were continuously stirred
and purged with nitrogen. Number of electrons n was
calculated using the equation Q¼nFN, where Q is the charge
in coulombs, F is the Faraday constant, and N is the number
of moles of substrate. Number of electrons involved in the
electrode process was found four at 1.2 V and six at 1.7 V.
3.8. Reaction mechanism
On the basis DPV, CV, square wave voltammetry and
coulometry following mechanism may be postulated for the
Table 4 Assay of midazolam by the voltammetric method and comparison with reference HPLC method.
Proposed method Reference method
Label claim (mg/mL) Mean (mg/mL) Label claim (%) RSD (%) Mean (mg/mL) Label claim (%) RSD (%)
1 0.97 97 3.78 1.03 103.0 1.02
Proposed method—voltammetric method developed in-house.
Reference method—HPLC method for midazolam assay mentioned in British Pharmacopoeia (BP).
Label claim—label claim of midazolam in midazolam injection.
Mean—mean of assay results obtained in three determinations.
RSD—% RSD of assay results obtained in three determinations.
Figure 6 HPLC chromatogram of midazolam (100 mg/mL) using
YMC ODS column (250 mm 4.6 mm, 5 mm) at a ﬂow rate of
1.0 mL/min, detection at 220 nm with mobile phase (Methanol:
Solution A: 72:28, v/v). Solution A was prepared by mixing equal
volume of 0.1 M ortho-phosphoric acid and 0.03 M triethyl,
adjusted pH 3.5 by 0.1 M NaOH.
Scheme 1 Reaction mechanism for reduction of midazolam.
R. Jain, R.K. Yadav128reduction of midazolam (Scheme 1). Peak labeled as 0 may be
a pre-adsorption peak not affected by the concentration of the
analyte. Peak 1 may be assigned to the 2-electron reduction
of –C¼N– bond of the seven membered ring, peak 2 to the
2-electron reduction of –C¼N– bond of the ﬁve memberedring and peak 3 to the 2-electron reduction of –C¼C– of the
ﬁve membered ring of midazolam [14–16].4. Conclusion
The electrochemical behavior of midazolam at glassy carbon
electrode is studied using SWV, CV and DPV techniques in the
presence of surfactants for the ﬁrst time. This work has demon-
strated that midazolam has three reduction peaks at glassy carbon
electrode in presence of 0.1% SLS solution. It showed irreversible
process corresponding to reduction of midazolam. On the basis of
SWV, CV, DPV and coulometric studies a six electron mechanism
has been suggested for the reduction of the drug. Peak current
could be enhanced by the addition of cationic surfactant SLS.
From the analytical point of view largest peak was used to assay
determination of midazolam. After optimizing various operational
parameters analytical method for quantitation of midazolam with
good stability, high sensitivity and selectivity was developed and
validated. In addition, analysis was performed with good recov-
eries without any interference from the excipient. Owing to the
simple solution preparation and shorter run time of the proposed
procedure, the method can be suggested as a good alternative for
the assay determination of midazolam over HPLC method.References
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